Supernus Pharmaceuticals Inc’s filing revealed that its Sr. VP of IP, CSO Bhatt Padmanabh P. unloaded Company’s shares for reported $0.79 million on Dec 03 ’24. In the deal valued at $36.68 per share,21,495 shares were sold. As a result of this transaction, Bhatt Padmanabh P. now holds 9,679 shares worth roughly $0.36 million.
Then, PADMANABH P BHATT bought 21,495 shares, generating $801,978 in total proceeds.
Before that, NEWHALL CHARLES W III sold 10,700 shares. Supernus Pharmaceuticals Inc shares valued at $387,768 were divested by the Director at a price of $36.24 per share. As a result of the transaction, NEWHALL CHARLES W III now holds 130,275 shares, worth roughly $4.83 million.
Cantor Fitzgerald initiated its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight in a research note published on January 06, 2025; the price target was $57. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in mid September from “an Overweight” to “a Neutral”.
Price Performance Review of SUPN
On Monday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock jump 0.35% to $37.05. Over the last five days, the stock has lost -0.35%. Supernus Pharmaceuticals Inc shares have risen nearly 2.46% since the year began. Nevertheless, the stocks have risen 33.56% over the past one year. While a 52-week high of $39.37 was reached on 01/06/25, a 52-week low of $25.53 was recorded on 01/02/25. SMA at 50 days reached $36.08, while 200 days put it at $31.95.
Levels Of Support And Resistance For SUPN Stock
The 24-hour chart illustrates a support level at 36.46, which if violated will result in even more drops to 35.86. On the upside, there is a resistance level at 37.99. A further resistance level may holdings at 38.92. The Relative Strength Index (RSI) on the 14-day chart is 57.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.41%. Stochastics %K at 74.05% indicates the stock is a holding.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2024-12-13, growing by 0.11 million shares to a total of 6.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.52 million shares. There was a rise of 1.72%, which implies that there is a positive sentiment for the stock.